Skip to content
SCL

STEPAN CO

STEPAN CO Q3 FY2024 earnings call

October 30, 2024 · fiscal period ended 2024-09

EPS · actual vs est

$1.03 / $0.65Beat +58.5%

Revenue · actual vs est

$546.8M / $530.3MBeat +3.1%
Ask about this call

Summary

Generated 2024-10-30

Management highlights

  • The Board appointed Luis Rojo as President and CEO effective immediately. - Third quarter adjusted EBITDA was $53 million, up 11% versus prior year. Adjusted net income was $23.7 million, a 61% increase year-over-year. - On track to deliver $50 million cost reduction goal for 2024. - Executed tax projects reducing effective tax rate for 2024 to 19%-20%. - Surfactant business had double-digit volume growth; focus on Tier 2 and Tier 3 customers; diversification into functional products; Pasadena alkoxylation facility 99% complete.
View in transcript ↓

Segment performance

Surfactant: Net sales for the quarter were $383 million, a 2% increase versus the prior year. Adjusted EBITDA increased $12.6 million or 40% versus the prior year. Polymers: Net sales were $150 million, a 12% decrease versus the prior year. Adjusted EBITDA decreased $6.3 million or 21% versus the prior year. Specialty Products: Net sales were $14.3 million, a 24% decrease versus the prior year. Adjusted EBITDA increased $1.3 million or 33% versus the prior year.

View in transcript ↓

Guidance

  • Expect to return to lower inventory levels during Q4 2024. - Free cash flow was positive at $7 million for the first nine months of 2024 and confident of positive free cash flow for full year 2024. - Pasadena alkoxylation production facility expected to have full contribution growth rate achieved in the second half of 2025.
View in transcript ↓

Risks

  • Global and regional economic conditions. - Prospects for foreign operations. - Macro-economic uncertainties impacting Polymers business. - $3.3 million related to Asia fraud event, an isolated and contained event.
View in transcript ↓

Q&A highlights

Q: Mike Harrison inquired about Ag business recovery, Europe Surfactant performance, Consumer Surfactant trends, and EBITDA potential.

A: Luis Rojo responded on Ag business growth, positive trends in Europe Surfactant, Consumer Surfactant ups and downs with Laundry and Cleaning business strength, and discussed EBITDA excluding one-time impacts.

Q: Dave Storms asked about Rigid Polyol catalysts, Surfactant customer mix improvement, and Q4 maintenance.

A: Luis Rojo talked about Rigid Polyol market outlook with interest rate moderation, Surfactant Tier 2/3 customer acquisition strategy, and Q4 Polymers turnarounds.

Q: David Silver questioned CapEx outlook, marketing efforts with Tier 2/3 customers, and strategic direction change.

A: Luis Rojo discussed CapEx returning to normal level, marketing focus on Tier 2/3 customers, and emphasis on surgical changes to accelerate growth while maintaining core strategic areas.

View in transcript ↓

Key numbers

Reported versus consensus

Earnings calendar feed

MetricReportedConsensusDeltaPrior year
EPS$1.03$0.65+58.5%$0.64
Revenue$546.8M$530.3M+3.1%$562.2M

Transcript

October 30, 2024

Full transcript unavailable for redistribution

The structured summary above covers the available call sections. Full transcript text is not included on this page.

Continue exploring

Prior quarters

This page presents the stored structured earnings-call summary and deterministic earnings calendar values. How this is generated. For informational purposes only; not investment advice.